Cargando…

Evaluation of limited-sampling strategies to calculate AUC((0–24)) and the role of CYP3A5 in Chilean pediatric kidney recipients using extended-release tacrolimus

Background: Kidney transplantation (KTx) requires immunosuppressive drugs such as Tacrolimus (TAC) which is mainly metabolized by CYP3A5. TAC is routinely monitored by trough levels (C(0)) although it has not shown to be a reliable marker. The area-under-curve (AUC) is a more realistic measure of dr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galvez, Carla, Boza, Pía, González, Mariluz, Hormazabal, Catalina, Encina, Marlene, Azócar, Manuel, Castañeda, Luis E., Rojo, Angélica, Ceballos, María Luisa, Krall, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043346/ https://www.ncbi.nlm.nih.gov/pubmed/36998611 http://dx.doi.org/10.3389/fphar.2023.1044050

Ejemplares similares

CYP3A5 and UGT1A9 Polymorphisms Influence Immunosuppressive Therapy in Pediatric Kidney Transplant Recipients
por: Krall, Paola, et al.
Publicado: (2021)

Analyses of AUC((0–12)) and C(0) Compliances within Therapeutic Ranges in Kidney Recipients Receiving Cyclosporine or Tacrolimus
por: Radzevičienė, Aurelija, et al.
Publicado: (2020)

Pharmacokinetic evaluation of MFF in combinations with tacrolimus and cyclosporine. Findings of C(0) and AUC
por: Radzevičienė, Aurelija, et al.
Publicado: (2020)

Fasting Status and Circadian Variation Must be Considered When Performing AUC‐based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant Recipients
por: Gustavsen, Marte Theie, et al.
Publicado: (2020)

CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
por: Chen, Lucy, et al.
Publicado: (2018)

The Open AUC Project
por: Cölfen, Helmut, et al.
Publicado: (2009)

1090. Does calculation method matter for targeting vancomycin AUC?
por: Chang, Jack, et al.
Publicado: (2021)

Analytical Ultracentrifugation (AUC): An Overview of the Application of Fluorescence and Absorbance AUC to the Study of Biological Macromolecules
por: Edwards, Garrett B., et al.
Publicado: (2020)

Effect of CYP3A4, CYP3A5, MDR1 and POR Genetic Polymorphisms in Immunosuppressive Treatment in Chilean Kidney Transplanted Patients
por: Contreras-Castillo, Stephania, et al.
Publicado: (2021)

CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients
por: Déri, Máté, et al.
Publicado: (2021)

Correcting AUC for Measurement Error
por: Rosner, Bernard, et al.
Publicado: (2015)

The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
por: Lunde, Ingrid, et al.
Publicado: (2014)

CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients
por: Li, Yi, et al.
Publicado: (2015)

Composite CYP3A (CYP3A4 and CYP3A5) phenotypes and influences on tacrolimus dose adjusted concentration in adult heart transplant recipients
por: Hernandez, Savine, et al.
Publicado: (2023)

Quantifying relative virulence: when μ (max) fails and AUC alone just is not enough
por: Ceballos, Ruben Michael, et al.
Publicado: (2020)

Direct AUC optimization of regulatory motifs
por: Zhu, Lin, et al.
Publicado: (2017)

Investigation of clinical interaction between omeprazole and tacrolimus in CYP3A5 non-expressors, renal transplant recipients
por: Katsakiori, Paraskevi F, et al.
Publicado: (2010)

Influence of CYP3A5 polymorphism on tacrolimus drug dosing in Indian renal allograft recipients: initial experience
por: Patel, Mohan, et al.
Publicado: (2014)

Differences in CYP3A genotypes of a liver transplant recipient and the donor liver graft and adjustment of tacrolimus dose
por: Berger, Florine A., et al.
Publicado: (2019)

AucPR: An AUC-based approach using penalized regression for disease prediction with high-dimensional omics data
por: Yu, Wenbao, et al.
Publicado: (2014)

Drug-induced CYP induction as therapy for tacrolimus intoxication
por: Hoppe, John M., et al.
Publicado: (2022)

Plasmapheresis Reduces Mycophenolic Acid Concentration: A Study of Full AUC(0–12) in Kidney Transplant Recipients
por: Piyasiridej, Sudarat, et al.
Publicado: (2019)

Evaluation of a Novel Glucose Area Under the Curve (AUC) Monitoring System: Comparison with the AUC by Continuous Glucose Monitoring
por: Ugi, Satoshi, et al.
Publicado: (2016)

Impact of the CYP3A5, CYP3A4, COMT, IL-10 and POR Genetic Polymorphisms on Tacrolimus Metabolism in Chinese Renal Transplant Recipients
por: Li, Chuan-Jiang, et al.
Publicado: (2014)

Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients
por: Kagaya, Hideaki, et al.
Publicado: (2018)

Influence of CYP3A5 and ABCB1 Polymorphism on Tacrolimus Drug Dosing in South Indian Renal Allograft Recipients
por: Fernando, M. Edwin, et al.
Publicado: (2019)

Donor CYP3A5 Gene Polymorphism Alone Cannot Predict Tacrolimus Intrarenal Concentration in Renal Transplant Recipients
por: Zhang, Mengyu, et al.
Publicado: (2020)

Impact of Tacrolimus Daily Dose Limitation in Renal Transplant Recipients Expressing CYP3A5: A Retrospective Study
por: Lenain, Rémi, et al.
Publicado: (2021)

ARCS/AUCS: A rare clinicoradiological presentation
por: George, Pratish, et al.
Publicado: (2008)

Stability selection for LASSO with weights based on AUC
por: Kwon, Yonghan, et al.
Publicado: (2023)

Rocker: Open source, easy-to-use tool for AUC and enrichment calculations and ROC visualization
por: Lätti, Sakari, et al.
Publicado: (2016)

Tacrolimus trough levels in kidney transplant recipients
por: Hwang, Young Hui, et al.
Publicado: (2021)

The Clinical Impact of the C(0)/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
por: van Gelder, Teun, et al.
Publicado: (2020)

Effect of CYP3A4 and PPARA polymorphism on concentration-to-dose ratio and adverse effects of tacrolimus in Pakistani liver transplant recipients
por: Azam, Fahad, et al.
Publicado: (2022)

A Randomized Pharmacokinetic Study of Generic Tacrolimus Versus Reference Tacrolimus in Kidney Transplant Recipients
por: Alloway, R R, et al.
Publicado: (2012)

A new donors’ CYP3A5 and recipients’ CYP3A4 cluster predicting tacrolimus disposition, and new-onset hypertension in Chinese liver transplant patients
por: Liu, Yuan, et al.
Publicado: (2017)

Characteristics and calculations of paired vancomycin measurements for determination of 24-h area-under-curve (AUC)
por: Deng, Yutao, et al.
Publicado: (2023)

Simulation of the AUC Changes after Generic Substitution in Patients
por: Yim, Dong-Seok
Publicado: (2009)

An Adaptive Moment estimation method for online AUC maximization
por: Liu, Xin, et al.
Publicado: (2019)

Educational Resource Review: The case for AUC dosing of vancomycin
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ovdb7b2sk3jho38jes9loq0qtq